Cargando…

The evolving role of immuno‐oncology for the treatment of head and neck cancer

Monoclonal antibodies (mAbs) that target immune co‐signaling pathways have the potential to enable immune mediated tumor eradication. While early adoption of these agents for the treatment of advanced squamous cell carcinoma of the head and neck (SCCHN) has produced some astounding clinical successe...

Descripción completa

Detalles Bibliográficos
Autores principales: Strome, Arianna L., Zhang, Xiaoyu, Strome, Scott E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383301/
https://www.ncbi.nlm.nih.gov/pubmed/30828620
http://dx.doi.org/10.1002/lio2.235

Ejemplares similares